Page last updated: 2024-10-23

bepridil and Carcinoma, Squamous Cell of Head and Neck

bepridil has been researched along with Carcinoma, Squamous Cell of Head and Neck in 1 studies

Bepridil: A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist.
bepridil : A tertiary amine in which the substituents on nitrogen are benzyl, phenyl and 3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl.

Research Excerpts

ExcerptRelevanceReference
"Taking the intersection part of 27 HNSCC-related Kyoto Encyclopedia of Genes and Genomes pathways and 33 drug-affected pathways, we retained 22 candidate drugs corresponding to two key pathways (cell cycle and p53 signaling pathways) of the five overlapping pathways."1.51Drug repositioning in head and neck squamous cell carcinoma: An integrated pathway analysis based on connectivity map and differential gene expression. ( Chen, G; Gao, L; Liang, LB; Lin, P; Tang, ZY; Wei, GG; Zeng, JJ; Zhang, LC, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wei, GG1
Gao, L1
Tang, ZY1
Lin, P1
Liang, LB1
Zeng, JJ1
Chen, G1
Zhang, LC1

Other Studies

1 other study available for bepridil and Carcinoma, Squamous Cell of Head and Neck

ArticleYear
Drug repositioning in head and neck squamous cell carcinoma: An integrated pathway analysis based on connectivity map and differential gene expression.
    Pathology, research and practice, 2019, Volume: 215, Issue:6

    Topics: Antineoplastic Agents; Bepridil; Boronic Acids; Computational Biology; Drug Repositioning; Gene Expr

2019